Susan M. Swetter, MD, on Molecular Testing for Cutaneous Melanoma
NCCN 2021 Virtual Annual ConferenceSusan M. Swetter, MD, of Stanford Cancer Institute, discusses molecular prognostic tests for cutaneous melanoma, which may improve staging accuracy, reduce unnecessary sentinel lymph node biopsies, and inform decisions on surveillance imaging and/or adjuvant therapy.